TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM NEW
Total 13F shares
56,278,827
Share change
-4,266,083
Total reported value
$455,421,637
Put/Call ratio
40%
Price per share
$8.09
Number of holders
83
Value change
-$7,576,465
Number of buys
51
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2020

As of 30 Jun 2020, TRILLIUM THERAPEUTICS INC - COM NEW was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,278,827 shares. The largest 10 holders included VR Adviser, LLC, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Avoro Capital Advisors LLC, BOXER CAPITAL, LLC, CITADEL ADVISORS LLC, FRAZIER MANAGEMENT LLC, EVENTIDE ASSET MANAGEMENT, LLC, Marshall Wace North America L.P., and Ghost Tree Capital, LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.